Aridis Pharmaceuticals, Inc.
ARDS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $22,157 | $28,639 | $55,654 | $37,639 |
| - Cash | $4,876 | $19,986 | $8,232 | $20,897 |
| + Debt | $6,130 | $5,978 | $715 | $0 |
| Enterprise Value | $23,411 | $14,631 | $48,137 | $16,742 |
| Revenue | $0 | $0 | $1,000 | $1,022 |
| % Growth | – | -100% | -2.2% | – |
| Gross Profit | $0 | $0 | $1,000 | $1,022 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$29,506 | -$44,433 | -$22,064 | -$28,749 |
| % Margin | – | – | -2,206.4% | -2,813% |
| Net Income | -$30,749 | -$42,281 | -$22,333 | -$29,681 |
| % Margin | – | – | -2,233.3% | -2,904.2% |
| EPS Diluted | -1.64 | -3.44 | -2.44 | -3.43 |
| % Growth | 52.3% | -41% | 28.9% | – |
| Operating Cash Flow | -$29,127 | -$22,936 | -$20,476 | -$8,159 |
| Capital Expenditures | -$82 | -$530 | -$367 | -$174 |
| Free Cash Flow | -$29,209 | -$23,466 | -$20,843 | -$8,333 |